The First International Congress on Head and Neck Paragangliomas in 2023 launched a global initiative directed towards improving the management of head and neck paragangliomas (HNPGLs), including prevention, treatment and research. The Congress highlighted a lack of international evidence-based consensuses and guidelines for HNPGLs. The Congress will now convene triennially to foster personalized medicine and research to advance patient care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pacak, K., Eisenhofer, G. & Tischler, A. S. Phaeochromocytoma-advances through science, collaboration and spreading the word. Nat. Rev. Endocrinol. 16, 621–622 (2020).
Tooker, E. L. et al. The natural history of observed SDHx-related head and neck paragangliomas using three-dimensional volumetric tumor analysis. Otol. Neurotol. 44, 931–940 (2023).
Jansen, T. T. G., Timmers, H. J. L. M., Marres, H. A. M. & Kunst, H. P. M. Feasibility of a wait-and-scan period as initial management strategy for head and neck paraganglioma. Head Neck 39, 2088–2094 (2017).
Richter, S. et al. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Endocr. Relat. Cancer 29, 213–224 (2022).
McCrary, H. C. et al. Characterization of malignant head and neck paragangliomas at a single institution across multiple decades. JAMA Otolaryngol. Head Neck Surg. 145, 641–646 (2019).
Taïeb, D. et al. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 11, 345–361 (2023).
Prasad, S. C. et al. The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas. Otol. Neurotol. 35, 922–931 (2014).
Lloyd, S., Obholzer, R. & Tysome, J. BSBS Consensus Group. British Skull Base Society clinical consensus document on management of head and neck paragangliomas. Otolaryngol. Head Neck Surg. 163, 400–409 (2020).
Sanna, M., Piazza, P., Shin, S.-H., Flanagan, S. & Mancini, F. Microsurgery of Skull Base Paraganglioma (Thieme, 2013).
Pamporaki, C. et al. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort. Lancet Digit. Health 5, e551–e559 (2023).
Acknowledgements
R.M.-C. acknowledges the support of Head and Neck Paraganglioma Research Grants AIRC IG 16932 and AIRC IG 24501, supported by Fondazione AIRC per la Ricerca sul Cancro, viale Isonzo 25, 20135 Milano, Italy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
First International Congress, 2023 Update on the Management of Head and Neck Paragangliomas: https://paragangliomas.com
Rights and permissions
About this article
Cite this article
Sanna, M., Pacak, K., Taїeb, D. et al. A congress on head and neck paragangliomas: advancing clinical care. Nat Rev Endocrinol (2024). https://doi.org/10.1038/s41574-024-00987-9
Published:
DOI: https://doi.org/10.1038/s41574-024-00987-9